Click any title in the list below to view the article in it's entirety.
-
Status of OTC Epinephrine Inhaler
-
Drugs and Taste Disturbances
-
New Drugs of 2005
-
Recommendations against Amantadine and Rimantadine for Influenza
-
The Safety of Artificial Sweeteners
-
Thyroid Boosters
-
Alternatives to Pseudoephedrine 1005
Lead author: Gayle Nicholas Scott, Pharm.D., BCPS, ELS, Assistant Editor
-
Cardiovascular Safety of Viagra 1005
Lead author: Kathy Hitchens, Pharm.D., MSBA
-
High-dose, Short-course Levaquin (Leva-pak) for Acute Bacterial Rhinosinusitis1005
Lead author: Wan-Chih Tom, Pharm.D.
-
Influenza Update 1005
Reprinted from the CDC's recommendations for the prevention and control of influenza (July 29, 2005)
-
Treatments for Insomnia
Lead authors: Kelly M. Shields, Pharm.D. and Beth A. Lesher, RPh, Pharm.D., BCPS
-
Sublingual Viagra (Sildenafil)
Lead author: Cynthia Borda, Pharm.D., MBA
-
Effects of Heat on Transdermal Drug Patches
Lead Author: Wan-Chih Tom, Pharm.D.
-
Zmax (Azithromycin Extended Release for Oral Suspension)
Lead author: Neeta Bahal O'Mara, Pharm.D., BCPS
-
Omega-3 Fatty Acids
Lead author: Gayle Nicholas Scott, Pharm.D., BCPS, ELS, Assistant Editor
-
Pharmacogenomics: An Update
Lead author: Beth A. Lesher, Pharm.D., BCPS
-
STATISTICALLY significant or CLINICALLY significant?
Worksheet* to Evaluate Drug Studies
-
Trimethoprim-Sulfamethoxazole (TMP-SMX) for Community-Acquired Methicillin-Resistant Staphylococcus aureus
Lead author: Neeta Bahal O'Mara, Pharm.D., BCPS
-
Viagra and Vision Loss
Lead author: Cynthia Borda, Pharm.D., MBA
-
New Drug: Tygacil (Tigecycline)
Lead author: Kathy Hitchens, Pharm.D., MSBA
-
FDA Announces Important Changes and Additional Warnings for COX-2s and NSAIDs
From the FDA's Public Health Advisory concerning new changes and warnings for COX-2s and NSAIDs (April 7, 2005).
-
A Different Drug, a Different Country, but the Same Brand Name?
Lead author: Joseph A. Woelfel, Ph.D., FASCP, R.Ph
-
FDA Public Health Advisory on Crestor (rosuvastatin)
Evaluation and Research, concerning the revised labeling as well as muscle and kidney safety review for Crestor, March 2, 2005.
-
Ibuprofen and the Risk of Stevens-Johnson Syndrome
Lead author: Neeta Bahal O'Mara, Pharm.D., BCPS
-
Supplements for Migraine
Lead author: Gayle Nicholas Scott, Pharm.D., BCPS, ELS
-
Sports Injuries Are on the Rise
Guido R. Zanni, PhD, and Jeannette Yeznach Wick, RPh, MBA
-
Update on the Safety and Use of COX-2 Inhibitors and Traditional NSAIDs
Lead author: Beth A. Lesher, Pharm. D., BCPS
-
Community-Acquired MRSA 1104
Lead author: Narinder M. Duggal, BSc(Pharm), CDE, MD, FRCPC, FASCP
-
Influenza Antiviral Medications
Excerpts from the Centers for Disease Control and Prevention
-
Safety of COX-2 Inhibitors
Lead author: Beth A. Lesher, PharmD, BCPS
-
CDC Warns Against Resistant Staph Strain
NATA News
-
Beckett points finger at blister ointment
BY SARAH TALALAY
South Florida Sun-Sentinel
-
Oral versus Topical NSAIDs in Rheumatic Diseases: A Comparison
Catherine A. Heyneman,1 Cara Lawless-Liday1 and Geoffrey C. Wall2
1 Department of Pharmacy Practice and Administrative Sciences, Idaho State University College of Pharmacy, Pocatello, Idaho, USA
2 Department of Pharmacy Practice, Drake University College of Pharmacy, Des Moines, Iowa, USA
-
Iontophoresis
Prepared by Ryan Hansen, Pharm D. Candidate Edited by Mike Pavlovich, Pharm D. Produced by Robert Nickell, Pharmacist
-
Adherence to Drug-Dispensation and Drug-Administration Laws and Guidelines in Collegiate Athletic Training Rooms
Leamor Kahanov; David Furst; Sam Johnson; Jeff Roberts
-
Federal Regulations specific to the management of prescription medications in the athletic training medical facility.
-
The pitch: No more blisters
A potion cooked up by a Dodger trainer is catching on among ballplayers and other athletes.
By Shari Roan, Times Staff Writer
-
Tissue Rubs™ Diadermals™ LipoDermals™
Documented by Bhavesh Desai, InternPharmacist Edited by Mike Pavlovich, Pharm.D.
Produced by Robert Nickell, Pharmacist
- True stories of violations and abuses.